1. Chu Q, Liu P, Song Y, Yang R, An J, Zhai X, Niu J, Yang C, Li B. Stearate-derived very long-chain fatty acids are indispensable to tumor growth. EMBO J. 2023 Jan 16;42(2):e111268. doi: 10.15252/embj.2022111268. Epub 2022 Nov 21. Erratum in: EMBO J. 2023 Sep 4;42(17):e114802. doi: 10.15252/embj.2023114802. PMID: 36408830; PMCID: PMC9841326.

2. Yang R, Yang C, Ma L, Zhao Y, Guo Z, Niu J, Chu Q, Ma Y, Li B. Identification of purine biosynthesis as an NADH-sensing pathway to mediate energy stress. Nat Commun. 2022 Nov 17;13(1):7031. doi: 10.1038/s41467-022-34850-0. PMID: 36396642; PMCID: PMC9672040.

3. Jin X, Li X, Li L, Zhong B, Hong Y, Niu J, Li B. Glucose-6-phosphate dehydrogenase exerts antistress effects independently of its enzymatic activity. J Biol Chem. 2022 Dec;298(12):102587. doi: 10.1016/j.jbc.2022.102587. Epub 2022 Oct 13. PMID: 36243112; PMCID: PMC9667318.

4. Zhang X, Tian Y, Xu L, Fan Z, Cao Y, Ma Y, Li H, Ren F. CRISPR/Cas13-assisted hepatitis B virus covalently closed circular DNA detection. Hepatol Int. 2022 Apr;16(2):306-315. doi: 10.1007/s12072-022-10311-0. Epub 2022 Mar 17. PMID: 35298777; PMCID: PMC9013339.

5. Gao H, Xu L, Fan Z, Zhang X, Duan Z, Ren F. The Role of Autophagy in the Mother-to-Child Transmission of Pregnant Women With a High Level of HBV DNA. Front Cell Infect Microbiol. 2022 Apr 22;12:850747. doi: 10.3389/fcimb.2022.850747. PMID: 35531331; PMCID: PMC9072787.

6. Xu L, Zhang X, Cao Y, Fan Z, Tian Y, Zou H, Ma Y, Duan Z, Ren F. Digital Droplet PCR for Detection and Quantitation of Hepatitis Delta Virus. Clin Transl Gastroenterol. 2022 Jul 1;13(7):e00509. doi: 10.14309/ctg.0000000000000509. Epub 2022 Jun 8. PMID: 35905419; PMCID: PMC10476728.

7. Fan Z, Li Y, Chen S, Xu L, Tian Y, Cao Y, Pan Z, Zhang X, Chen Y, Ren F. Magnesium Isoglycyrrhizinate Ameliorates Concanavalin A-Induced Liver Injury by Inhibiting Autophagy. Front Pharmacol. 2022 Jan 4;12:794319. doi: 10.3389/fphar.2021.794319. PMID: 35058778; PMCID: PMC8763799.

8. Guan B, Ren F, Shan W, Zhang S. Molecular subtypes of m6A RNA methylation modification patterns and their clinical significance in clear cell renal cell carcinoma. Transl Cancer Res. 2022 Mar;11(3):508-518. doi: 10.21037/tcr-22-117. PMID: 35402182; PMCID: PMC8990822.

9. Chen S, Ren F, Huang X, Xu L, Gao Y, Zhang X, Cao Y, Fan Z, Tian Y, Liu M. Underestimated Prevalence of HIV, Hepatitis B Virus (HBV), and Hepatitis D Virus (HDV) Triple Infection Globally: Systematic Review and Meta-analysis. JMIR Public Health Surveill. 2022 Nov 29;8(11):e37016. doi: 10.2196/37016. PMID: 36445732; PMCID: PMC9748799.

10. Wei L, Wang T, Chen S, Liu Y, Huang X, Zheng S, Xu B, Ren F, Liu M. Serum Anti-Fumarate Hydratase Autoantibody as a Biomarker for Predicting Prognosis of Acute-on-Chronic Liver Failure. Gut Liver. 2023 Sep 15;17(5):795-805. doi: 10.5009/gnl220022. Epub 2022 Nov 1. PMID: 36317513; PMCID: PMC10502492.

11. Zhang Y, Wang L, Bai L, Jiang R, Wu J, Li Y. Ebosin Attenuates the Inflammatory Responses Induced by TNF-α through Inhibiting NF-κB and MAPK Pathways in Rat Fibroblast-Like Synoviocytes. J Immunol Res. 2022 Mar 17;2022:9166370. doi: 10.1155/2022/9166370. PMID: 35340587; PMCID: PMC8947919.

12. Wang Z, Zhang Y, Yang R, Wang Y, Guo J, Sun R, Zhou Y, Su L, Ge Q, Feng Y. Landscape of Peripheral Blood Mononuclear Cells and Soluble Factors in Severe COVID-19 Patients With Pulmonary Fibrosis Development. Front Immunol. 2022 Apr 26;13:831194. doi: 10.3389/fimmu.2022.831194. PMID: 35558069; PMCID: PMC9088015.

13. Xie F, Xu HF, Zhang J, Liu XN, Kou BX, Cai MY, Wu J, Dong JL, Meng QH, Wang Y, Chen D, Zhang Y. Dysregulated hepatic lipid metabolism and gut microbiota associated with early-stage NAFLD in ASPP2-deficiency mice. Front Immunol. 2022 Nov 18;13:974872. doi: 10.3389/fimmu.2022.974872. PMID: 36466835; PMCID: PMC9716097.

14. Yao J, Yang H, Wang H, Shi H, Jiao Y, Zhang Y, Chen D, Shi H. ASPP2 Coordinates ERS-Mediated Autophagy and Apoptosis Through mTORC1 Pathway in Hepatocyte Injury Induced by TNF-α. Front Pharmacol. 2022 Mar 28;13:865389. doi: 10.3389/fphar.2022.865389. PMID: 35418864; PMCID: PMC8996113.

15. Duan B, Zhang G, Wang W, Yin J, Liu M, Zhang J, Chen D, Ouyang Y, Li G. Immunogenicity profiling and distinct immune response in liver transplant recipients vaccinated with SARS-CoV-2 inactivated vaccines. Front Immunol. 2022 Sep 14;13:954177. doi: 10.3389/fimmu.2022.954177. PMID: 36189318; PMCID: PMC9517166.

16. Gao Y, Xu Q, Li X, Guo Y, Zhang B, Jin Y, Zhu C, Shen Y, Yang P, Shi Y, Jin R, Liu D, Ouyang Y, Liu X, Wang W, Chen D, Yang T. Heterogeneity induced GZMA-F2R communication inefficient impairs antitumor immunotherapy of PD-1 mAb through JAK2/STAT1 signal suppression in hepatocellular carcinoma. Cell Death Dis. 2022 Mar 7;13(3):213. doi: 10.1038/s41419-022-04654-7. PMID: 35256589; PMCID: PMC8901912.

17. Li C, Zhou T, Chen J, Li R, Chen H, Luo S, Chen D, Cai C, Li W. The role of Exosomal miRNAs in cancer. J Transl Med. 2022 Jan 3;20(1):6. doi: 10.1186/s12967-021-03215-4. PMID: 34980158; PMCID: PMC8722109.

18. Chen H, Chen J, Yuan H, Li X, Li W. Hypoxia-inducible factor-1α: A critical target for inhibiting the metastasis of hepatocellular carcinoma. Oncol Lett. 2022 Jun 28;24(2):284. doi: 10.3892/ol.2022.13404. PMID: 35814827; PMCID: PMC9260738.

19. Li X, Wang W, Chen J, Xie B, Luo S, Chen D, Cai C, Li C, Li W. The potential role of exosomal miRNAs and membrane proteins in acute HIV-infected people. Front Immunol. 2022 Aug 12;13:939504. doi: 10.3389/fimmu.2022.939504. PMID: 36032099; PMCID: PMC9411714.

20. Chen H, Shang X, Yuan H, Niu Q, Chen J, Luo S, Li W, Li X. Total flavonoids of Oldenlandia diffusa (Willd.) Roxb. suppresses the growth of hepatocellular carcinoma through endoplasmic reticulum stress-mediated autophagy and apoptosis. Front Pharmacol. 2022 Nov 29;13:1019670. doi: 10.3389/fphar.2022.1019670. PMID: 36523497; PMCID: PMC9745173.

21. Lin T, Wang S, Munker S, Jung K, Macías-Rodríguez RU, Ruiz-Margáin A, Schierwagen R, Liu H, Shao C, Fan C, Feng R, Yuan X, Wang S, Wandrer F, Meyer C, Wimmer R, Liebe R, Kroll J, Zhang L, Schiergens T, Ten Dijke P, Teufel A, Marx A, Mertens PR, Wang H, Ebert MPA, Bantel H, N De Toni E, Trebicka J, Dooley S, Shin D, Ding H, Weng HL. Follistatin-controlled activin-HNF4α-coagulation factor axis in liver progenitor cells determines outcome of acute liver failure. Hepatology. 2022 Feb;75(2):322-337. doi: 10.1002/hep.32119. Epub 2021 Dec 14. PMID: 34435364.

22. Liu B, Wang S, Xu M, Ma Y, Sun R, Ding H, Li L. The double-edged role of hydrogen sulfide in the pathomechanism of multiple liver diseases. Front Pharmacol. 2022 Dec 16;13:899859. doi: 10.3389/fphar.2022.899859. PMID: 36588686; PMCID: PMC9800830.

23. Chan L, Pang Y, Wang Y, Zhu D, Taledaohan A, Jia Y, Zhao L, Wang W. Genistein-induced mitochondrial dysfunction and FOXO3a/PUMA expression in non-small lung cancer cells. Pharm Biol. 2022 Dec;60(1):1876-1883. doi: 10.1080/13880209.2022.2123933. PMID: 36200643; PMCID: PMC9553144.

24. Wu X, Wang Y, Wang W. The Role of Peptidyl Arginine Deiminase IV(PADI4) in Cancers. Anticancer Agents Med Chem. 2023;23(3):256-265. doi: 10.2174/1871520622666220614115309. PMID: 35702765.

25. Ge P, Liu C, Chan L, Pang Y, Li H, Zhang Q, Ye X, Wang J, Wang R, Zhang Y, Wang W, Zhang D, Zhao J. High-Dimensional Immune Profiling by Mass Cytometry Revealed the Circulating Immune Cell Landscape in Patients With Intracranial Aneurysm. Front Immunol. 2022 Jun 27;13:922000. doi: 10.3389/fimmu.2022.922000. PMID: 35833148; PMCID: PMC9271834.

26. Liu S, Yin R, Yang Z, Wei F, Hu J. The effects of rhein on D-GalN/LPS-induced acute liver injury in mice: Results from gut microbiome-metabolomics and host transcriptome analysis. Front Immunol. 2022 Oct 27;13:971409. doi: 10.3389/fimmu.2022.971409. PMID: 36389730; PMCID: PMC9648667.

27. Wu HX, Hou W, Zhang W, Wang Z, Guo S, Chen DX, Li Z, Wei F, Hu Z. Clinical evaluation of bacterial DNA using an improved droplet digital PCR for spontaneous bacterial peritonitis diagnosis. Front Cell Infect Microbiol. 2022 Aug 18;12:876495. doi: 10.3389/fcimb.2022.876495. PMID: 36061877; PMCID: PMC9433567.

28. Yin R, Liu S, Jiang X, Zhang X, Wei F, Hu J. The Qingchangligan Formula Alleviates Acute Liver Failure by Regulating Galactose Metabolism and Gut Microbiota. Front Cell Infect Microbiol. 2022 Jan 19;11:771483. doi: 10.3389/fcimb.2021.771483. PMID: 35127552; PMCID: PMC8807683.

29. Xie B, Hao Q, Zhou X, Chen D. Inactivation of tumor suppressor TAp63 by hepatitis B virus X protein in hepatocellular carcinoma. Chin Med J (Engl). 2022 Jul 20;135(14):1728-1733. doi: 10.1097/CM9.0000000000002283. PMID: 35950770; PMCID: PMC9509107.

30. Yin X, Xue R, Wu J, Wu M, Xie B, Meng Q. PINK1 ameliorates acute-on-chronic liver failure by inhibiting apoptosis through mTORC2/AKT signaling. Cell Death Discov. 2022 Apr 23;8(1):222. doi: 10.1038/s41420-022-01021-5. PMID: 35461334; PMCID: PMC9035184.

31. Wu J, Xue R, Wu M, Yin X, Xie B, Meng Q. Nrf2-Mediated Ferroptosis Inhibition Exerts a Protective Effect on Acute-on-Chronic Liver Failure. Oxid Med Cell Longev. 2022 Apr 16;2022:4505513. doi: 10.1155/2022/4505513. PMID: 35480867; PMCID: PMC9036161.

32. Huo Y, Cao K, Kou B, Chai M, Dou S, Chen D, Shi Y, Liu X. TP53BP2: Roles in suppressing tumorigenesis and therapeutic opportunities. Genes Dis. 2022 Sep 5;10(5):1982-1993. doi: 10.1016/j.gendis.2022.08.014. PMID: 37492707; PMCID: PMC10363587.

33. 產(chǎn)柳佳,楊舒雯,閆亞冬,等.黃芪多糖對(duì)肝癌Hep G2.215細(xì)胞的抑制作用及其機(jī)制研究[J].傳染病信息,2022,35(02):130-134.

34. 高玉雪,寧琪琪,蔡玉瑩,等. 錯(cuò)配修復(fù)基因在乙型肝炎病毒相關(guān)肝細(xì)胞癌中表達(dá)的影響因素[J]. 中國(guó)醫(yī)藥導(dǎo)報(bào),2022,19(31):31-34,48. DOI:10.20047/j.issn1673-7210.2022.31.07.

35. 范子豪,田原,徐玲,等.基于微滴式數(shù)字PCR技術(shù)對(duì)乙型肝炎低病毒血癥患者血漿HBV DNA精準(zhǔn)檢測(cè)[J].臨床檢驗(yàn)雜志,2022,40(02):87-91.DOI:10.13602/j.cnki.jcls.2022.02.02.

36. 龐麗君,裴明霞,劉凱,等.聚合酶鏈?zhǔn)椒磻?yīng)實(shí)驗(yàn)技術(shù)在培養(yǎng)醫(yī)學(xué)研究生科研能力中的探索分析[J].中國(guó)醫(yī)藥導(dǎo)報(bào),2022,19(13):68-70.DOI:10.20047/j.issn1673-7210.2022.13.012.

37. 渠亞超,殷繼明,任鋒,等.脫細(xì)胞人羊膜支架材料對(duì)羊膜源性干細(xì)胞增殖作用的影響[J].西部醫(yī)學(xué),2022,34(05):639-643.

38. 張文彥,劉芳,劉夢(mèng)露,等.非酒精性脂肪性肝病患者血漿外泌體差異蛋白分析[J].實(shí)用肝臟病雜志,2022,25(04):521-525.

39. 張文彥,劉芳,劉夢(mèng)露,等.酒精性肝病患者血漿外泌體差異蛋白的分析[J].胃腸病學(xué)和肝病學(xué)雜志,2022,31(02):146-152+157.

40. 時(shí)紅波,焦彥,時(shí)紅林,等.雨課堂在傳染病教學(xué)中的應(yīng)用與推廣[J].醫(yī)學(xué)教育管理,2022,8(02):164-167.

41. 柴夢(mèng)音,寇卜心,伏志,等. 索拉非尼通過(guò)調(diào)控Runt相關(guān)轉(zhuǎn)錄因子3-血管內(nèi)皮生長(zhǎng)因子通路抑制肝癌血管生成[J]. 中華肝臟病雜志,2022,30(7):770-776. DOI:10.3760/cma.j.cn501113-20201221-00670.

42. 柴夢(mèng)音,寇卜心,豆雙雙,等. 黃芪超微粉抗急性肝損傷、抗疲勞作用及黃芪甲苷含量的變化[J]. 現(xiàn)代中醫(yī)藥,2022,42(5):26-32. DOI:10.13424/j.cnki.mtcm.2022.05.005.

43. 寇卜心,柴夢(mèng)音,豆雙雙,等. 黃芪超微粉對(duì)環(huán)磷酰胺致免疫失衡小鼠免疫功能的影響[J]. 亞太傳統(tǒng)醫(yī)藥,2022,18(1):22-26. DOI:10.11954/ytctyy.202201006.

44. 寇卜心,柴夢(mèng)音,豆雙雙,等. p53凋亡刺激蛋白2基因肝臟條件性敲除小鼠的構(gòu)建和鑒定[J]. 實(shí)用肝臟病雜志,2022,25(2):170-174. DOI:10.3969/j.issn.1672-5069.2022.02.005.